contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


axichem-ab-axichem-and-canadian-based-iovate-sign-letter-of-intent-regarding-development-and-commercialization-of-axivite-as-ingredient-in-weight-management-supplement

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

aXichem is active in industrial biotechnology. The company develops, patents and markets industrial chemicals. The company mainly works with Phenylcapsaicin, a natural analog synthetic capsaicin with applications in a variety of areas, such as in the marine sector, among pest control in forestry and agriculture, as well as among individual pharmaceutical work areas. Operations are run on a global level, with the head office in Malmö.

aXichem

Iovate is one of the world's leading suppliers of products for weight management. Founded in 1995 and based in Oakville, Canada, Iovate is a dynamic, leading-edge nutritional company that delivers...

Iovate is one of the world's leading suppliers of products for weight management. Founded in 1995 and based in Oakville, Canada, Iovate is a dynamic, leading-edge nutritional company that delivers some of the highest quality, most innovative and effective active nutrition products in the world. With brand innovations like MuscleTech®, Six Star Pro Nutrition®, Purely Inspired® and Hydroxycut®, the company is committed to being the number one active nutrition and weight management supplement company in the world. Iovate distributes across all major channels of distribution, including food, drug, mass and club, health food stores and online, as well as in more than 130 countries worldwide. Iovate products are available nationwide in the US at GNC, the Vitamin Shoppe, Bodybuilding.com, Walmart, Target, Walgreen's, Sam's Club, Amazon.com and other fine retailers. -  I am very pleased with having entered into this LOI with Iovate and I look forward to collaborate with one of the world leaders in the area of nutrition and supplements - and not least in weight management products, an area where we expect aXivite to be an excellent fit. Under the signed LOI we will jointly develop and commercialize a product ingredient for weight management aimed for the U.S. market. The LOI is valid until 1 January 2021, but both parties are eager to get started and explore the potential that both of us see in aXivite, says Lucas Altepost, Vice President at aXichem. -  We are looking forward to collaborate with aXichem in bringing this new product ingredient to the market, with the goal to add another successful brand to our already strong portfolio and help people reach their weight loss goals. aXivite, being an analogue of capsaicin, has attributes that we feel provide it the potential to add significant value in our range of weight management products, says Raza Bashir, Vice President, Scientific Affairs, Innovation &amp; Procurement at Iovate.   The U.S. market for weight management products amounted to about 66 billion USD in 2017 according ResearchAndMarkets.com. The global market for for weight management and weight control products is expected to reach over 442 billion USD year 2025, with a calculated average growth rate of about 8.2% for the period according to marketwatch.com.  This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version.

aXichem AB: aXichem and Canadian based Iovate sign Letter of Intent regarding development and commercialization of aXivite, as ingredient in weight management supplement

Tilmeld dig vores nyhedsbrev - ingen konto nødvendig!